Novartis (Switzerland)

23.3k papers and 1.1M indexed citations i.

About

In recent decades, authors affiliated with Novartis (Switzerland) have published 23.3k papers, which have received a total of 1.1M indexed citations. Scholars at this organization have produced 7.4k papers in Molecular Biology, 2.7k papers in Oncology and 2.4k papers in Organic Chemistry on the topics of Neuroscience and Neuropharmacology Research (751 papers), Chemical Synthesis and Analysis (718 papers) and Receptor Mechanisms and Signaling (699 papers). Their work is cited by papers focused on Molecular Biology (385.2k citations), Oncology (131.3k citations) and Immunology (101.2k citations). Authors at Novartis (Switzerland) collaborate with scholars in Switzerland, United States and Germany and have published in prestigious journals including Nature, Science and Cell. Some of Novartis (Switzerland)'s most productive authors include Matthias Staufenbiel, Doriano Fabbro, Volker Brinkmann, Pascal Furet and F. Gasparini.

In The Last Decade

Fields of papers published by authors at Novartis (Switzerland)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novartis (Switzerland) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novartis (Switzerland)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (Switzerland). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Switzerland) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Switzerland) more than expected).

Rankless by CCL
2025